pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·14h ago·1 min read
save

Calls to Ban Prior Authorizations Amid Hospital Job Cuts Highlight Health‑Care Policy Debate

Aug 10, 2026·read at STAT ↗Neutral

The Health Care Inc. newsletter from STAT highlighted a proposal to eliminate most prior authorizations, a requirement that insurers use to control drug spending.

The suggestion comes from policy advocate Hannah Garden‑Monheit, who argues that the process creates delays and administrative burden for patients and providers.

At the same time, the newsletter notes that hospitals are experiencing workforce reductions, partly linked to recent restrictions on the 340B drug discount program.

The combined issues underscore ongoing tensions between cost‑containment measures and the operational challenges facing health‑care providers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Ban prior auth? And hospitals cut jobs”

read at STAT ↗
455 words · retrieved 14h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.
topics
Vaccine2mRNA TherapeuticmRNA Vaccine

related stories

  • 21h agoOpinion: We prepared for Ebola — but not this EbolaSTAT
  • 21h agoOpinion: We prepared for Ebola — but not this EbolaSTAT
  • 3d agoOpinion: Fauci doesn’t have the answers on Covid’s origins. China doesSTAT
  • 3d agoIs the biotech capital of the world moving?STAT
  • 3d agoOpinion: AI won’t enhance physician autonomy. It will further diminish itSTAT